Skip to article
Astra

Infectious Diseases

Lyme Disease

Diagnose Lyme disease from syndrome-specific pretest probability, use validated two-tier serology when confirmation changes management, recognize carditis and neurologic emergencies, and select short, manifestation-directed antibiotic courses while avoiding unnecessary prolonged therapy.

Clinical question: How should clinicians diagnose, triage, treat, and monitor suspected Lyme disease across its major clinical manifestations?

Initial decision

Triage by manifestation before ordering tests

Identify conduction disease, meningitis, radiculopathy, and inflammatory arthritis before interpreting serology.

Treat a patient with one or more classic erythema migrans lesions in an endemic area clinically, without laboratory confirmation. Serology is often insensitive early in infection, whereas an atypical expanding lesion or extracutaneous syndrome warrants validated two-tier testing because these presentations overlap with other illnesses. NatureRapid single-tier serodiagnosis of Lyme disease | Nature CommunicationsPubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI Bookshelf

Obtain a 12-lead ECG promptly for palpitations, presyncope or syncope, dyspnea, chest pain, or other concern for Lyme carditis. Lyme carditis affects the cardiac conduction system and can produce arrhythmia, poor cardiac function, hypotension, or syncope; symptomatic patients or those with clinically important conduction disease need hospital-level monitoring rather than outpatient empiric treatment alone. PubMedLyme disease: diagnosis and management

For acute facial palsy, painful radiculopathy, peripheral neuropathy, or meningitic symptoms after compatible tick exposure, distinguish peripheral neuroborreliosis from alternative infectious and inflammatory neuropathies. Neurologic manifestations have been reported in 3%-12% of Lyme disease cases and may occur with intense pain, facial palsy, radiculopathy, neuropathy, or meningitis. NatureLyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response | Scientific Reports

An acute or subacute large-joint inflammatory effusion, particularly a knee-predominant pattern, raises Lyme arthritis but should not defer arthrocentesis when septic arthritis remains plausible. Serology is the preferred diagnostic test for suspected Lyme arthritis; antibody testing of synovial fluid is not recommended. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease

Syndrome-based first action in suspected Lyme disease. BMJLyme disease - Management Approach | BMJ Best PracticePubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme DiseasePubMedLyme disease: diagnosis and managementPubMedLyme Disease - StatPearls - NCBI Bookshelf
PresentationImmediate actionTesting and interpretationTreatment direction
Classic erythema migrans in an endemic areaTreat clinically. PubMedLyme Disease - StatPearls - NCBI BookshelfDo not require serology before treatment. PubMedLyme Disease - StatPearls - NCBI BookshelfDoxycycline for 10 days or amoxicillin or cefuroxime axetil for 14 days. PubMedLyme Disease - StatPearls - NCBI Bookshelf
Atypical expanding lesion or extracutaneous syndromeEstimate epidemiologic and syndrome-specific pretest probability. IDSALyme DiseaseOrder standard or modified two-tier serum testing. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCIDSALyme DiseaseTreat according to the confirmed clinical manifestation. BMJLyme disease - Management Approach | BMJ Best PracticePubMedLyme Disease - StatPearls - NCBI Bookshelf
Palpitations, syncope, dyspnea, chest pain, conduction abnormalityObtain ECG; assess need for hospitalization and monitoring. PubMedLyme disease: diagnosis and managementEvaluate for Lyme carditis in a compatible exposure setting; exclude other causes of arrhythmia. PubMedLyme disease: diagnosis and managementOral doxycycline, amoxicillin, or cefuroxime if not hospitalized; total antibiotic duration 14-21 days. BMJLyme disease - Management Approach | BMJ Best Practice
Large-joint inflammatory arthritisExclude septic arthritis when clinically indicated.Use serum serology; avoid synovial-fluid antibody assays. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme DiseaseOral doxycycline for 28 days initially. PubMedLyme Disease - StatPearls - NCBI Bookshelf

Diagnostic testing

Use two-tier serology and interpret it in clinical time

A positive antibody result is meaningful only when the clinical syndrome and exposure risk support Lyme disease.

Use the CDC two-step algorithm for patients whose presentation requires laboratory confirmation. Standard two-tier testing uses a first-tier EIA followed, when the screen is positive or equivocal, by IgM and IgG immunoblotting; modified two-tier testing uses two different EIAs. The overall result is positive only when both tiers meet the assay-specific positivity criteria. If the first-tier test is negative, do not perform additional serologic testing in that specimen. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCIDSALyme Disease

Modified two-tier algorithms offer sensitivity comparable to conventional EIA-immunoblot testing and avoid subjective immunoblot interpretation. Their key limitation in late manifestations is that polyvalent EIAs may not distinguish IgM from IgG or show whether the IgG response is expanded, information that can be useful when evaluating suspected late Lyme arthritis. PubMedLaboratory Diagnosis of Lyme Borreliosis - PMCIDSALyme Disease

Time serology to the biology of the syndrome. Two-tier testing has low sensitivity in early infection, so a negative result does not exclude early erythema migrans; initially seronegative infected patients typically become strongly seropositive when retested several weeks later. Conversely, current assays do not distinguish active from remote infection, and seropositivity may persist for years. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease

Do not diagnose late Lyme disease from isolated IgM reactivity. IgM is relevant primarily during illness of less than 1 month; CDC case-definition criteria direct low-incidence states to disregard IgM results obtained more than 30 days after symptom onset. For conventional immunoblots, IgM positivity requires at least two of three designated bands, while IgG positivity requires at least five of ten designated bands. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC

Practical interpretation of Lyme laboratory testing. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCPubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme DiseaseCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC
Result or settingInterpretationNext action
Classic erythema migransEarly serology may be negative and is not required for diagnosis. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI BookshelfTreat clinically. PubMedLyme Disease - StatPearls - NCBI Bookshelf
Negative first-tier EIACDC two-step testing is negative; no second step is recommended. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCReassess pretest probability and alternate diagnoses; repeat after several weeks only if early compatible illness remains plausible. IDSALyme Disease
Positive/equivocal first-tier EIA with negative second tierDoes not establish seropositivity in the two-tier algorithm. PubMedLaboratory Diagnosis of Lyme Borreliosis - PMCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCDo not diagnose Lyme disease from the screening assay alone; reassess timing and differential.
Two-tier positive resultSupports exposure or infection in the appropriate clinical setting but does not prove active infection. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme DiseaseMatch treatment to an objective compatible manifestation.
IgM-only positivity after >30 daysHigh risk of misleading interpretation; late disease assessment should rely on IgG evidence. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedImmunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive ApproachesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDCEvaluate alternate diagnoses and avoid treating based on isolated late IgM.

Antimicrobial therapy

Choose treatment by objective manifestation and response

Use short, syndrome-directed courses; escalation depends on objective disease rather than residual nonspecific symptoms.

For erythema migrans without cardiovascular or neurologic involvement, use doxycycline for 10 days or amoxicillin or cefuroxime axetil for 14 days. Azithromycin for 5-10 days is a second-line option when the preferred agents cannot be used. Erythema migrans usually resolves within 1-2 weeks, while systemic symptoms can improve more slowly. PubMedLyme Disease - StatPearls - NCBI BookshelfPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf

Treat Lyme carditis for 14-21 days. Patients who do not require hospitalization can receive oral doxycycline, amoxicillin, or cefuroxime. Symptoms indicating conduction-system involvement require ECG-based triage and inpatient management when severe conduction disease or hemodynamic consequences are present. BMJLyme disease - Management Approach | BMJ Best PracticePubMedLyme disease: diagnosis and management

Treat Lyme arthritis with oral doxycycline for 28 days. A partial response can justify a second oral course, whereas minimal or absent response supports intravenous ceftriaxone for 2-4 weeks. After an oral course and an intravenous course, persistent inflammatory arthritis is postantibiotic Lyme arthritis; refer to rheumatology for consideration of intra-articular corticosteroid injection, disease-modifying antirheumatic therapy, or other advanced anti-inflammatory treatment rather than serial antibiotic courses. PubMedLyme Disease - StatPearls - NCBI Bookshelf

Counsel patients beginning antibiotics about Jarisch-Herxheimer reaction: transient fever, chills, myalgias, headache, and worsening of skin lesions can begin within 1-12 hours, usually resolves within 24-48 hours, and occurs in approximately 5%-15% of treated patients. Continue antibiotics and use acetaminophen or an oral NSAID for symptom control unless another acute process is suspected. PubMedLyme disease: diagnosis and managementPubMedLyme Disease - StatPearls - NCBI Bookshelf

Manifestation-directed treatment and reassessment. BMJLyme disease - Management Approach | BMJ Best PracticePubMedLyme Disease - StatPearls - NCBI BookshelfPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
ManifestationInitial regimenDurationReassessment trigger
Erythema migrans without neurologic or cardiac involvementDoxycycline; alternatives amoxicillin or cefuroxime axetil. PubMedLyme Disease - StatPearls - NCBI BookshelfDoxycycline 10 days; amoxicillin or cefuroxime 14 days. PubMedLyme Disease - StatPearls - NCBI BookshelfNew neurologic, cardiac, or objective articular findings require syndrome-specific reassessment.
Lyme carditis not requiring hospitalizationOral doxycycline, amoxicillin, or cefuroxime. BMJLyme disease - Management Approach | BMJ Best Practice14-21 days. BMJLyme disease - Management Approach | BMJ Best PracticeSyncope, dyspnea, chest pain, palpitations, or conduction disease warrants monitored evaluation. PubMedLyme disease: diagnosis and management
Lyme arthritisOral doxycycline. PubMedLyme Disease - StatPearls - NCBI Bookshelf28 days. PubMedLyme Disease - StatPearls - NCBI BookshelfPartial response may support a second oral course; minimal or no response supports intravenous ceftriaxone for 2-4 weeks. PubMedLyme Disease - StatPearls - NCBI Bookshelf
Postantibiotic Lyme arthritisRheumatologic anti-inflammatory strategy, including possible intra-articular corticosteroid or DMARD-based treatment. PubMedLyme Disease - StatPearls - NCBI BookshelfIndividualized.Avoid repeated antibiotic cycles after oral and intravenous treatment have failed to resolve synovitis. PubMedLyme Disease - StatPearls - NCBI Bookshelf

Persistent symptoms after treatment

Do not use persistence of fatigue, pain, or cognitive complaints alone as evidence of treatment failure. After early Lyme disease treatment, systemic complaints may persist at 3 months in approximately one in four patients, although most improve over time; reassess for objective recurrent or new Lyme manifestations and for non-Lyme explanations before considering further antimicrobial therapy. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf

Available controlled trials of prolonged antibiotic treatment in patients with persistent symptoms and a history of Lyme disease have been cited in neurologic reviews, while standard management sources describe typical treatment courses of 2-4 weeks and note no convincing evidence supporting prolonged treatment. The LancetLyme borreliosisNatureAn ultra-high-density protein microarray for high throughput ...

Prevention

Restrict post-exposure prophylaxis to high-risk Ixodes bites

Prophylaxis is not routine after every tick bite.

Offer antibiotic prophylaxis only when all high-risk criteria are satisfied: the removed tick is identified as adult or nymphal Ixodes scapularis, estimated attachment exceeds 36 hours, local tick infection prevalence with Borrelia burgdorferi exceeds 20%, doxycycline can be started within 72 hours of removal, and doxycycline is not contraindicated. The recommended regimen is a single dose of doxycycline. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf

Do not substitute another antibiotic for prophylaxis when doxycycline cannot be used, including pregnancy, lactation, or children younger than 8 years in the guideline criteria. Instead, provide symptom surveillance and instruct the patient to seek evaluation for erythema migrans, fever, facial palsy, new monoarthritis, or cardiopulmonary symptoms. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf

A negative history of a recognized tick bite should not exclude Lyme disease when an epidemiologically compatible syndrome is present; patient-recognized attachment is an imperfect exposure marker. Conversely, treating all nonspecific symptoms after a bite drives false-positive testing and unnecessary antibiotics because test specificity matters most in low-pretest-probability populations. PubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges

Eligibility screen for Lyme post-exposure prophylaxis. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Required criterionDecision consequence
Adult or nymphal Ixodes scapularis identifiedIf uncertain or not Ixodes, do not classify as high-risk prophylaxis exposure. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Estimated attachment >36 hoursShorter attachment does not meet the cited prophylaxis criterion. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Doxycycline can start within 72 hours of removalLater presentation does not meet the cited prophylaxis timing criterion. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Local Borrelia burgdorferi infection rate >20%Use local ecologic information rather than geography alone. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
No doxycycline contraindicationDo not use substitute prophylactic antibiotics; observe for early disease. PubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf

Follow-up

Monitor clinical endpoints, not antibody clearance

Persistent seropositivity is expected and should not determine cure or retreatment.

Follow erythema migrans by lesion evolution and systemic symptom trajectory, carditis by symptoms and ECG findings, and arthritis by joint examination and function. Do not order serial serology to document response because antibodies can persist for years and available assays cannot distinguish active from inactive infection. PubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges

If fever is prominent with thrombocytopenia or other laboratory abnormalities after Ixodes exposure, evaluate for tick-borne coinfection rather than attributing all findings to Lyme disease. A reported tick-borne case with fever and thrombocytopenia illustrates potential diagnostic overlap with ehrlichial illness, and Ixodes ticks may harbor Borrelia miyamotoi in addition to Lyme spirochetes. The LancetSupplementary appendix 1CDCPDF - 8.24 MB - 183 pages

For persistent or recurrent symptoms, re-anchor the diagnosis to objective evidence: a new erythema migrans lesion, a documented conduction abnormality, a compatible neurologic syndrome, or persistent inflammatory synovitis. In the absence of objective evidence, broaden the differential rather than using an isolated positive serologic result as proof of ongoing infection. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease

Common diagnostic errors and corrective actions. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme DiseaseCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDCPubMedLyme Disease - StatPearls - NCBI Bookshelf
ErrorWhy it misleadsCorrective action
Testing a classic erythema migrans lesion before treatingEarly serology has limited sensitivity and testing is unnecessary for a classic lesion. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI BookshelfTreat clinically with the recommended short oral regimen. PubMedLyme Disease - StatPearls - NCBI Bookshelf
Calling a first-tier EIA alone positiveTwo-tier testing requires concordant second-tier testing. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCComplete the two-step algorithm before interpreting serostatus. CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC
Using isolated late IgM as evidence of active Lyme diseaseIgM has limited relevance after the first month and can be falsely interpreted. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedImmunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive ApproachesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDCAssess IgG pattern, clinical syndrome, and alternate diagnoses.
Using repeat antibodies to explain ongoing symptomsSeropositivity can persist for years and does not establish active infection. PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesBase retreatment decisions on new objective manifestations.
Repeating antibiotics for refractory synovitis after oral and intravenous therapyPersistent disease may be postantibiotic inflammatory arthritis. PubMedLyme Disease - StatPearls - NCBI BookshelfRefer for rheumatologic management, including consideration of intra-articular corticosteroid or DMARD therapy. PubMedLyme Disease - StatPearls - NCBI Bookshelf

References

  1. Clinical characteristics and serological profiles of Lyme ...www.thelancet.com · www.thelancet.com
  2. Systematic comparisons between Lyme disease and post ...www.thelancet.com · www.thelancet.com
  3. Lyme borreliosiswww.thelancet.com · www.thelancet.com
  4. Lyme disease - Management Approach | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  5. Supplementary appendix 1www.thelancet.com · www.thelancet.com
  6. Rapid single-tier serodiagnosis of Lyme disease | Nature Communicationswww.nature.com · www.nature.com
  7. Lyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response | Scientific Reportswww.nature.com · www.nature.com
  8. Pilot study of psilocybin in patients with post-treatment lyme disease | Scientific Reportswww.nature.com · www.nature.com
  9. An ultra-high-density protein microarray for high throughput ...www.nature.com · www.nature.com
  10. Infectious Neuropathiesjournals.lww.com · journals.lww.com
  11. Lyme disease : Current Opinion in Rheumatologyjournals.lww.com · journals.lww.com
  12. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  13. Laboratory Diagnosis of Lyme Borreliosis - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  14. Clinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCwww.cdc.gov · www.cdc.gov
  15. Laboratory Diagnosis of Lyme Disease - Advances and Challengespmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  16. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approachespmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  17. Lyme Diseasewww.idsociety.org · www.idsociety.org
  18. Lyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDCndc.services.cdc.gov · ndc.services.cdc.gov
  19. PDF - 8.24 MB - 183 pageswwwnc.cdc.gov · wwwnc.cdc.gov
  20. Lyme disease: diagnosis and management - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  21. Lyme disease: diagnosis and managementwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. Lyme Disease - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  23. Commissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  24. IDSA 2020 Guideline on Diagnosis and Management of Babesiosiswww.idsociety.org · www.idsociety.org